Topic: ESOPRS 2021 ePoster sessions
Time: Sep 17, 2021 16:00 Amsterdam, Berlin, Rome, Stockholm, Vienna, 15:00 London
The zoom session will be a MEETING. Please turn off your camera and mic, unless prompted by the moderators during Q&A. When you enter the meeting there will be 2 BREAKOUT ROOMS. Please choose the appropriate room to join once you have joined the meeting.
The link details are below (you need to be logged in)
You are currently not logged in. If you have an account on this website please login to your account. Not registered yet? Signup here
(plain text version here)
Peri-ocular Mycobacterium infection post botulinum toxin injection
Author: Manvi Sobti
ePoster Number: 271
To highlight this rare periocular infection and successful multi-disciplinary management with a photo series
An 83-year-old patient with a history of treated breast cancer and active systemic immunosuppression for rheumatoid arthritis and Crohn’s disease, presented with a 1 cm nodular lesion in the lateral canthal area three months following botulinum toxin injections for hemifacial spasm. Excisional biopsy demonstrated mycobacterial infection and PCR analysis of the histopathology sample was suggestive of non-tubercular mycobacteria. Whole genomic sequencing identified the species as Mycobacterium Fortuitum. The same organism was identified on asymptomatic sputum analysis, with normal chest CT imaging. Despite repeated complete excision of the lesion, the lesion rapidly regrew to double the original size within eight weeks and orbital involvement was the concern. Empirical treatment with cotrimoxazole and doxycycline was initiated, subsequently modified to ciprofloxacin and doxycycline following antibiotic sensitivities. Complete resolution was seen with seven weeks of treatment. Treatment was planned for four
months but in view of complete resolution of symptoms and significant gastrointestinal and tendonitis side effects the treatment had to be discontinued. However, the patient remains disease-free two months after cessation of all the
Peri-ocular infections with mycobacterium fortuitum are extremely rare and involvement following botulinum toxin injections has not been reported before. The key factors in successful management include TB PCR from the histopathology specimens alongside genomic analysis and antibiotic sensitivity tests. These allow individually tailored treatment strategies.Multidisciplinary team management with Microbiology, TB specialists remain criticalin successful disease management.
|First name||Last name||Base Hospital / Institution|
|Richard||Scawn||Chelsea and Westminster Hospital|
Abstract ID: 21-174